Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.

GRDN

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.69B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Guardian Pharmacy Services, Inc.Guardian Pharmacy Services, Inc.49.9-24%1.80.2
$41.67

Target Price by Analysts

6.3% upsideGuardian Pharmacy Services Target Price DetailsTarget Price
$67.20

Current Fair Value

71.5% upside

Undervalued by 71.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.69 Billion
Enterprise Value$2.66 Billion
Dividend Yield$- (-)
Earnings per Share$0.79
Beta0.08
Outstanding Shares63,321,000

Return

Return on Equity24.02%ROE
Return on Assets12.43%
Return on Invested Capital35.03%

Valuation & Multiples

P/E Ratio49.89P/E Ratio
PEG122.54PEG
Price to Sales1.78Price to Sales
Price to Book Ratio13.06Price to Book Ratio
Enterprise Value to Revenue1.83
Enterprise Value to EBIT28.48
Enterprise Value to Net Income50
Total Debt to Enterprise0.01
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 18, 2026
EPS Estimate
$0.24
Average shareholder expectation
Revenue Estimate
$331.65 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 10, 2026
EPS Estimate
$0.26
Average shareholder expectation
Revenue Estimate
$340.45 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts6,600 83.50%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %44.71% 12.63%
Total Invested$1.07B 77.69%
Investors Holding171 42.00%

ESG Score

No data

About Guardian Pharmacy Services, Inc.

3,400 employees
CEO: Mr. Fred P. Burke

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug ...